Abstract
Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA
This evaluation found that the majority of patients on antipsychotic agents do not have all baseline monitoring completed, and that there are significant gaps especially in lipid panel and hemoglobin A1c. Other parameters (e.g., blood pressure, weight) were more likely to be gathered, likely as part of routine visit procedure.
Document Type
Poster
Publication Date
12-2024
Recommended Citation
Yarian, Kendra PharmD; Gilbert, Jenna PharmD, BCPP; Stabler, Libby PharmD, BCACP; Nguyen, Quyen PharmD, BCACP; and Gaddis, Leia PharmD, BCPS, DPLA, "Evaluation of cardiometabolic monitoring in patients taking antipsychotic agents within a community health system." (2024). Pharmacy Residency. 30.
https://researchrepository.parkviewhealth.org/pharmresidency/30